PW Medtech Group (HKSE:01358) 3-Year FCF Growth Rate : 19.30% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group 3-Year FCF Growth Rate?

PW Medtech Group's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.06.

During the past 12 months, PW Medtech Group's average Free Cash Flow per Share Growth Rate was -39.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 12 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of PW Medtech Group was 58.70% per year. The lowest was -56.00% per year. And the median was 27.05% per year.

Competitive Comparison of PW Medtech Group's 3-Year FCF Growth Rate

For the Medical Instruments & Supplies subindustry, PW Medtech Group's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PW Medtech Group's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's 3-Year FCF Growth Rate falls into.

PW Medtech Group 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

PW Medtech Group (HKSE:01358) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

PW Medtech Group 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (HKSE:01358) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

PWE:Germany

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

Executives

Right Faith Holdings Limited	2101 Beneficial owner
Chan Marc	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc	2101 Beneficial owner
Cross Mark Limited	2101 Beneficial owner
Liu Yufeng	2201 Interest of corporation controlled by you
Zhang Zaixian	2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines